0 General Meeting ASX:RCE | FSE:R9Q September 2026 Disclaimer DISCLAIMER This presentation has been prepared by Recce Pharmaceuticals Ltd (the “Company”). It does not purport to contain all the information that a prospective investor may require in connection with any potential...
General Meeting Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
In the deck
Story so far
Earlier from Recce Pharmaceuticals
- Appendix 4E and FY26 Annual Report
- Appendix 4G
- HREC Approves Comparator Study for Pivotal Phase 3 DFI
- Change of Director's Interest Notices (x4)
- Cleansing Notice
Later from Recce Pharmaceuticals
- Results of General Meeting
- 2026 Annual General Meeting
- Resolutions under section 249N of the Corporations Act
- Notification of cessation of securities - RCE
- Notice of Annual General Meeting/Proxy Form
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals